Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05268341 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neuroimaging Reveals Treatment-related Changes in DLD

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment target: 184 to 100v7
  2. Primary and study completion dates: Jun 30, 2026 to Jun 30, 2027 Site details revised at 1 of 6 sitesv6 Show 1 more changeShow less
    • Site details revised at 1 of 6 sites
  3. Primary and study completion dates: Jun 2026 to Jun 30, 2026v5
  4. Re-verified, no change to tracked fieldsv4
  5. Trial status: Not Yet Recruiting to Recruiting Study sites: 1 to 6 · Start date changed from estimate of Jun 2022 to May 24, 2022 · Collaborators: 1 to 2 · 1 morev3 Show 4 more changesShow less
    • Study sites: 1 to 6
    • Start date changed from estimate of Jun 2022 to May 24, 2022
    • Collaborators: 1 to 2
    • Eligibility criteria expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  6. Start date: Apr 2022 to Jun 2022 Primary completion date: Dec 2025 to Jun 2026v2 Show 1 more changeShow less
    • Primary completion date: Dec 2025 to Jun 2026
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Children with developmental language disorders (DLD, aka specific language impairment), a prevalent pediatric disorder, experience hallmark grammar deficits with life-long impacts on educational and occupational outcomes. While effective and early interventions can mitigate the impact of DLD, not enough is known about the neural basis of DLD in young children, yet is needed to inform the design of more individualized interventions. This project uses neuroimaging, along with behavioral methods, with the goal of better understanding the memory-language mechanisms that underlie grammar learning and impairment, while also considering their association to treatment-related changes in preschoolers with DLD.
Trial Details
NCT Number NCT05268341
Lead Sponsor University of Cincinnati
Collaborators: Children's Hospital Medical Center, Cincinnati, University of Toronto
Conditions Developmental Language Disorder
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov